Élan
Elan Corporation plc was a major drugs firm based in
Irish Stock Exchange as ELN.I, and the London Stock Exchange as ELN.L. In 2013, the company merged with Perrigo to form Perrigo Company PLC.[2]
History
The company was founded in Ireland by American businessman
accounting scandal and investor reactions to the global slump, caused a major devaluation resulting in a share price slump of over 90%.[3] In July 2010, Élan was fined $203m for its marketing of epilepsy drugs.[4]
In February 2013, Elan decided to dispose of the rights to sell Tysabri to
Biogen Idec for $3.25 billion.[5]
Products in development
In
Phase II clinical trial presented in July 2008 were inconclusive, Elan is hopeful that bapineuzumab will prove successful in the treatment of this disease.[7]
In autoimmune diseases, Elan’s primary emphasis was studying cell trafficking to discover ways to provide disease-modifying therapies for
Biogen Idec and Élan as "Tysabri". Tysabri is a monoclonal antibody that inhibits immune cells from crossing blood vessel walls to reach various tissues, including the brain. It has proven efficacy in the treatment of two serious autoimmune disorders: multiple sclerosis, and Crohn's disease.[8]
[9]
References
- ^ a b c Annual Report 2012
- ^ "Perrigo Company plc Completes Acquisition of Élan Corporation, plc" (Press release). Perrigo. 18 December 2013. Archived from the original on 22 February 2014. Retrieved 21 February 2014.
- ^ Ireland's troubled Élan Corp. says SEC is investigating its accounting practices AP, 7 February 2002
- ^ insideireland.ie, Elan fined $203m over drug marketing, Elan fined $203m over drug marketing, 16 July 2010. Accessed 19 July 2010.
- ^ Biogen to Pay Elan $3.25 Billion for Full Tysabri Rights Bloomberg, 6 February 2013
- ^ "Lilly halts Alzheimer's drug development". PM Live. 18 August 2010. Retrieved 25 January 2020.
- ^ Elan, Wyeth’s Alzheimer’s Angst Builds as Rivals Fail Bloomberg, 20 July 2009
- ^ "Tysabri Label Change to Target Use". Bloomberg.com. 20 January 2012.
- ^ "Elan's lawn irks". Houseofbrands. 20 January 2012.
External links
| International | |
|---|---|
| National | |
